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ABSTRACT
Vitamin D (Vit D) is a prohormone that can be activated during a sequential hydroxylation done 
by two major mitochondrial cytochrome P450 liver and renal enzymes. Vit D-dependent rickets 
type 1 (VDDR1) is a rare autosomal recessive hereditary disorder resulting from defective renal 
1α-OHase presenting with severe rickets, hypocalcemia, and secondary hyperparathyroidism. 
Although homozygous Vit D hydroxylation deficient patients develop severe rickets symptom 
and signs before the age of 12 months, heterozygous types have minor symptoms and are 
extremely rare presenting as late as 14 years after birthday. Here we present a suspicious case of 
VDDR1 at 21 years old of age with mild symptoms and signs.
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Active vitamin D (Vit D) is one of the most important regu-
latory hormones playing a critical role in blood minerals ho-
meostasis, especially calcium. There are two forms of Vit D, 
Ergocalciferol (Vit D2) produced by plants and cholecalcif-
erol (Vit D3) which is generated by animal tissues and in hu-
mans, synthesized by the skin from 7-dehydrocholestrol un-
der the action of ultraviolet light (1). Whether it is digested 
or synthesized in the skin, Vit D is a prohormone or inactive 
hormone that can be activated during a sequential hydrox-
ylation done by two major mitochondrial cytochrome P450 
liver, and renal enzymes which named Vit D 25-hydroxylase 
and 25-hydroxy Vit D-1α-hydroxylase (1α-OHase), respec-
tively (1-3). When the blood levels of calcium or 1,25(OH)2D 
decreases and phosphate increases, parathyroid hormone 
(PTH) is released (3). Rickets defined as defective miner-
alization of skeleton before epiphyseal closure, is one of the 
most common pediatric diseases (4). Rickets affects an esti-
mated 1 in 200,000 children, however, hereditary types, espe-
cially Vit D-dependent rickets type 1 (VDDR1), is much less 
common and its prevalence is unknown (5). Typical rickets 
symptoms include growth retardation, joint widening (such 
Published by Mehrabani Publishing LLC.  
Copyright (c) the author(s). This is an open access article under CC BY license (https://creativecommons.org/licenses/by/4.0/)  
http://dx.doi.org/10.24200/imminv.v1i2.27
as ankles, wrists and costochondral), seizure episodes, fron-
tal bossing, and proximal muscle weakness (6). The VDDR1 
also as know Vit D hydroxylation deficient rickets type 1 or 
pseudo-Vit D deficiency rickets type 1, is a rare autosomal 
recessive hereditary disorder resulting from defective renal 
1α-OHase presenting with severe rickets, hypocalcemia, and 
secondary hyperparathyroidism (7). Although homozygous 
Vit D hydroxylation deficient patients develop severe rick-
ets symptom and signs before the age of 12 months, het-
erozygous types have minor symptoms and are exceedingly 
rare (8). Up to now, about 68 mutations in 1α-OHase have 
been reported worldwide (7, 9). Here we report a case suspi-
cious for a kind of Vit D hydroxylation deficient rickets with 
late onset and presenting with only chronic low back pain 
and proximal myopathy.
CASE PRESENTATION
A 21-year old girl admitted to the endocrinology ward due 
to proximal muscle weakness, chronic low back pain, and 
occasional tetany from 8 years ago. Her low back pain was 
the prominent location of pain, and she was complaining of 
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a whole body pain and weakness that the pain was persistent 
and aggravated by normal daily activity. She reported diffi-
culty to stand up without the assistant of hands due to muscle 
weakness especially from 4 years ago. She was also com-
plaining of loss of appetite and myalgia especially for shoul-
der and pelvic girdle muscles. Her past medical history was 
normal, and there was no history of thyroid, parathyroid, and 
kidney diseases. On physical examination, she was lethargic 
but co-operative, she was not febrile, there was no tachycar-
dia or tachypnea and her blood pressure was 130/70 mmHg 
within the normal range. Her chest expansion was normal, and 
no kyphosis or scoliosis was seen. She exhibited carpopedal 
spasm when taking her pressure that occurred at 50 mmHg 
(Figure 1), but her Chvostek’s sign was negative. There was 
no clinical evidence of rickets including enamel hypoplasia 
and genu varum except muscle hypotonia specially proximal 
lower limb weakness (with a muscle strength of 3/5). Also, 
there was no radiological findings mainly widening of the 
wrists or Looser’s line in her pelvic and wrist x-rays graph. 
However, lowered bone density was seen in her pelvic x-ray 
graph. When she was asked to walk for assessing her gait the 
patient used circumduction for compensating her weakness 
and her gait was waddling. No other abnormality could be 
detected, and further investigations showed no biochemi-
cal evidence for malabsorption, renal, and hepatic disease. 
Echocardiography showed prolonged QT interval (Figure 
2). The biochemical analysis of the blood sample are pre-
sented in the Table 1. Regarding the Table 1, serum calcium 
and phosphorous levels were 7.4 mg/dl and 2.6 mg/dl that 
indicated the hypocalcemia and hypophosphatemia, respec-
tively. The blood alkaline phosphatase level was 1222 U/L 
(normal range less than 280 U/L) and the PTH level was 
189 ng/L (normal range less than 65 ng/L). X-rays imaging 
of her hand, legs and chest did not show any signs of rickets.
DISCUSSION
According to the history, lab data, and clinical course of our 
patient, her condition, and the laboratory rickets was not just 
due to Vit D deficiency, malabsorption, and chronic renal or 
hepatic disease. Although some disease like celiac and oth-
er malabsorption diseases cannot be ruled out without fur-
ther investigations like small intestine biopsy, generally it 
is felt that the tests were not indicated in such patient with 
the obvious wellbeing developmental and growth pattern re-
garding that her tissue transglutaminase antibody (anti- tTG) 
was negative. Also considering the child’s good response to 
the physiological dose of active Vit D, it is strong evidence 
against these conditions. Keeping the facts above in mind, 
and due to the hallmark biochemical findings in VDDR1 that 
are hypocalcemia, hypophosphatemia and raised serum level 
of PTH, the most likely diagnosis is a mild (heterozygous) 
variant of Vit D-dependent rickets. Although due to low lev-
el of 25OHD (less than 3 ng/ml), measuring 1,25(OH)2D 
was not valuable, but as mentioned before, not persistent 
Vit D deficiency and dairy-poor diet nor typical homozy-
gous VDDR1 can describe the late onset of symptoms and 
Figure 1: The patient carpal spasm during taking her blood 
pressure
Figure 2: Electrocardiograph of the patient. Note the location of T 
wave between R to R interval and prolonged QT
Table 1. Patient biochemical markers on admission
Marker Amount Normal range Units
WBC 5,400 4,500-11,000 µL
RBC 3,900,000 4.2-5.4 µL
Hb 12.1 12±2 gr/dL
MCV 91.8 80-96 fL
Plt 178,000 150-450×103 µL
ALT 7 Up to 50 U/L
AST 19 Up to 40 U/L
Alk-P 1137 44-147 IU/L
CPK 95 22-198 IU/L
ESR 10 Up to 29 mm/h
TSH 2.3 0.5-5 mIU/L
T3 1.38 0.5-1.5 ng/dL
T4 8.3 5-12 µg/dL
Urea 18 7-20 mg/dL
Cr 0.7 0.5-1.1 in females mg/dL
Ca 7.4 8-10 mg/dL
P 2.6 2.5-5.5 mg/dL
Na 138 135-145 mEq/L
K 3.6 3-5 mEq/L
Alb 4.1 3.5-5.5 g/dL
PTH 341 10-55 pg/mL
Vit D3 (25OH) <3 20-50 ng/mL
24h urine Ca 19 100-250 mg/d
24h urine P 240 170-1200 mg/d
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signs of the patient (7, 10). On the other hand, her phospho-
rus level was always around the lower limit of normal range 
while we expect lower levels in case of isolated Vit D defi-
ciency. Currently, some studies have shown these patients do 
not necessarily have the same autosomal recessive trait and 
therefore the phenotype is variable, and it is believed that if 
the defect was less severe, the presentation of the affected 
patients would be later (11, 12). The patient was treated by 
both Vit D3 and calcitriol, her symptoms was controlled, and 
on discharge, serum calcium level was 8.8 mg/dl and serum 
phosphorus level was 3.6 mg/dl with a high level of well- be-
ing. Finally, although the patient does need more follow-up 
and investigations, it seems that patient has a mild form of 
VDDR1 and needs daily active Vit D for preventing the pro-
gression of symptoms and signs.
CONCLUSION
Considering the essential roles of Vit D in major body miner-
als homeostasis mainly calcium and phosphorus, and plenty 
of other important functions like cell differentiation and im-
mune system modification and due to the high prevalence of 
Vit D deficiency, we should always think about it especially 
in those patients with musculoskeletal symptoms.
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